Tuadles, Reymark .

HRN: 29-08-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/03/2026
06/10/2026
IV
4.5
Q8
Cap MR
Rejected 
06/06/2026
LEVOFLOXACIN 500MG (TAB)
06/06/2026
06/12/2026
ORAL
500mg
OD
Aplastic Anemia
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: